Intermediates in SARS-CoV-2 Spike–Mediated Cell Entry

Investigators used an antiviral lipopeptide entry inhibitor to arrest S protein refolding and thereby capture intermediates as S proteins interacted with hACE2 and fusion-activating proteases on cell-derived target membranes.